Multikinase Inhibitors for the Treatment of Asymptomatic Radioactive Iodine-Refractory Differentiated Thyroid Cancer: Global Noninterventional Study (RIFTOS MKI).
Brose MS, Smit JWA, Lin CC, Tori M, Bowles DW, Worden F, Shen DH, Huang SM, Tsai HJ, Alevizaki M, Peeters RP, Takahashi S, Rumyantsev P, Guan R, Babajanyan S, Ozgurdal K, Sugitani I, Pitoia F, Lamartina L.
Brose MS, et al. Among authors: shen dh.
Thyroid. 2022 Sep;32(9):1059-1068. doi: 10.1089/thy.2022.0061.
Thyroid. 2022.
PMID: 35950621
Clinical Trial.